Anish Bhatnagar
Chief Executive Officer presso SOLENO THERAPEUTICS, INC.
Patrimonio netto: 7 M $ in data 31/03/2024
Profilo
Anish Bhatnagar is currently the President, Chief Executive & Operating Officer at Soleno Therapeutics, Inc. He previously worked as a Principal at Titan Pharmaceuticals, Inc. from 2000 to 2006.
He also held a position as a Principal at Coulter Corp.
Dr. Bhatnagar completed his undergraduate degree at SMS Medical College & Hospital.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
SOLENO THERAPEUTICS INC
0.47% | 01/04/2024 | 152 790 ( 0.47% ) | 7 M $ | 31/03/2024 |
Posizioni attive di Anish Bhatnagar
| Società | Posizione | Inizio |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Chief Executive Officer | 01/01/2017 |
Precedenti posizioni note di Anish Bhatnagar
| Società | Posizione | Fine |
|---|---|---|
| TITAN PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2006 |
| Coulter Corp | Corporate Officer/Principal | - |
Formazione di Anish Bhatnagar
| SMS Medical College & Hospital | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| TITAN PHARMACEUTICALS, INC. | Health Technology |
| SOLENO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
| Coulter Corp | Health Technology |
- Borsa valori
- Insiders
- Anish Bhatnagar
